πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Vericel Corporation

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

EVOMELA

CASI Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes therapeutics and pharmaceutical products focusing on markets in China, the United States, and internationally. Major products include EVOMELA and a pipeline with several investigational products targeting various cancers.

Tags: CAR-T, biopharmaceutical, cancer treatment, clinical trials, multiple myeloma, pharmaceutical, therapeutics

Symbol: CASI

Recent Price: $2.93

Industry: Biotechnology

CEO: Dr. Wei-Wu He Ph.D.

Sector: Healthcare

Employees: 176

Address: 9620 Medical Center Drive, Rockville, MD 20850

Phone: 240 864 2600

Last updated: 2024-12-31

Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

ELI-002

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for cancer and other diseases, with its lead product ELI-002 targeting KRAS-driven cancers.

Tags: Biotechnology, Cancer Treatment, Clinical-stage, Immunotherapy, Vaccines

Symbol: ELTX

Recent Price: $5.00

Industry: Biotechnology

CEO: Mr. Robert T. Connelly

Sector: Healthcare

Employees: 32

Address: 451 D Street, Boston, MA 02210

Phone: 857-209-0050

Last updated: 2024-12-31

Kiromic BioPharma, Inc.

Kiromic BioPharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

ALEXIS-ISO-1, ALEXIS-PRO-1

Kiromic Bio Pharma, Inc. is an artificial intelligence-driven allogeneic cell therapy company that develops multi-indication T cell therapies, leveraging the Gamma Delta T cell to target solid tumors. Key products include ALEXIS-ISO-1 and ALEXIS-PRO-1.

Tags: T cell therapies, artificial intelligence, biopharmaceutical, cell therapy, oncology

Symbol: KRBP

Recent Price: $0.93

Industry: Biotechnology

CEO: Mr. Pietro Bersani CPA, J.D.

Sector: Healthcare

Employees: 35

Address: 7707 Fannin, Houston, TX 77054

Phone: 832 968 4888

Leadership

  • Pietro Bersani, CPA, Director
  • Leonardo Mirandola, PhD, Chief Scientific Officer/Interim COO
  • Scott Dahlbeck, MD, PharmD, Chief of Staff
  • Brian Hungerford, Chief Financial Officer
  • Michael Nagel, Chairperson
  • Michael Catlin, Independent Director
  • Pam Misajon, Independent Director

Last updated: 2024-12-31

Artivion, Inc.

Artivion, Inc. logo
Market Cap: Medium
Employees: Medium

Bio Glue, Photo Fix, E-vita, E-xtra, E-nside, E-nya, E-ventus BX, E-liac, E-tegra

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues globally, offering a range of products for cardiac, vascular, neurologic, and pulmonary procedures.

Tags: Bio Glue, cardiac preservation, implantable tissues, medical devices, thoracic stent grafts, vascular treatments

Symbol: AORT

Recent Price: $28.59

Industry: Medical - Devices

CEO: Mr. James Patrick Mackin

Sector: Healthcare

Employees: 1500

Address: 1655 Roberts Boulevard N.W., Kennesaw, GA 30144

Phone: 770 419 3355

Last updated: 2024-12-31

Arcellx, Inc.

Arcellx, Inc. logo
Market Cap: High
Employees: Low

CART-dd BCMA

Arcellx, Inc. is a clinical-stage biotechnology company dedicated to developing immunotherapies for cancer and other incurable diseases, with a focus on its lead product candidate, CART-dd BCMA, for treating relapsed or refractory multiple myeloma.

Tags: acute myeloid leukemia, biotechnology, cancer treatment, clinical-stage, immunotherapy, multiple myeloma, myelodysplastic syndrome

Symbol: ACLX

Recent Price: $78.35

Industry: Biotechnology

CEO: Mr. Rami Elghandour

Sector: Healthcare

Employees: 130

Address: 25 West Watkins Mill Road, Gaithersburg, MD 20878

Phone: 240 327 0603

Last updated: 2024-12-31

Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

pegcetacoplan

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic compounds targeting the complement system for autoimmune and inflammatory diseases.

Tags: autoimmune diseases, biopharmaceutical, complement system, inflammatory diseases, pegcetacoplan, therapeutics

Symbol: APLS

Recent Price: $31.90

Industry: Biotechnology

CEO: Dr. Cedric Francois M.D., Ph.D.

Sector: Healthcare

Employees: 702

Address: 100 Fifth Avenue, Waltham, MA 02451

Phone: 617 977 5700

Leadership

  • Cedric Francois, MD, PhD, Co-Founder & Chief Executive Officer/President
  • Caroline Baumal, MD, Chief Medical Officer
  • Mark DeLong, Chief Business & Strategy Officer
  • Pascal Deschatelets, PhD, Co-Founder & Chief Scientific Officer
  • Jeffrey Eisele, PhD, Chief Development Officer
  • Karen Lewis, Chief People Officer
  • Nur Nicholson, Chief Technical Operations Officer
  • Timothy Sullivan, Chief Financial Officer
  • Adam Townsend, Chief Operating Officer
  • David Watson, JD, General Counsel
  • Apellis Pharmaceuticals,
  • Gerald Chan, Chairman
  • Sinclair Dunlop, Director
  • Stephanie Monaghan O’Brien, Director
  • Paul Fonteyne, Director
  • Cedric Francois, Co-Founder & Chief Executive Officer/President
  • Alec Machiels, Co-Founder

Last updated: 2024-12-31

Assembly Biosciences, Inc.

Assembly Biosciences, Inc. logo
Market Cap: Low
Employees: Low

Vebicorvir

Assembly Biosciences, Inc. is a clinical-stage biotechnology company focused on discovering and developing therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Their lead product candidate, Vebicorvir, has completed Phase 2 clinical trials. The company is engaged in additional development and collaboration agreements to advance treatments for HBV.

Tags: Vebicorvir, biotechnology, clinical trials, hepatitis B, therapeutics

Symbol: ASMB

Recent Price: $16.03

Industry: Biotechnology

CEO: Mr. Jason A. Okazaki

Sector: Healthcare

Employees: 65

Address: 331 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 833 509 4583

Last updated: 2024-12-31

BeiGene, Ltd.

BeiGene, Ltd. logo
Market Cap: Highest
Employees: Highest

BRUKINSA, Tislelizumab, REVLIMID, VIDAZA, XGEVA, BLINCYTO, KYPROLIS, SYLVANT, QARZIBA, Pamiparib, Pobevcy

Bei Gene, Ltd. is a biotechnology company focused on discovering, developing, manufacturing, and commercializing a wide range of medicines globally, specializing in oncology treatments and clinical stage drug candidates.

Tags: Biotechnology, Medicines, Oncology, Pharmaceuticals, Research and Development

Symbol: BGNE

Recent Price: $183.81

Industry: Biotechnology

CEO: Mr. John V. Oyler

Sector: Healthcare

Employees: 10000

Address: 55 Cambridge Parkway, Cambridge, MA 02142

Phone: 781-801-1800

Leadership

  • John V. Oyler, Co-Founder, Chairman and CEO
  • Xiaodong Wang, Ph.D., Co-Founder, Chairman of Scientific Advisory Board
  • Olivier Brandicourt, M.D., Director
  • Margaret Dugan, M.D., Director
  • Donald W. Glazer, Director
  • Michael Goller, Director
  • Anthony Hooper, Director
  • Ranjeev Krishana, Director
  • Michael Nuoqing Yi, Director
  • Alessandro Riva, M.D., Director
  • Corsee Sanders, Ph.D., Director
  • Shalini Sharp, Director
  • Steven Young, Ph.D., Acting Head of Medicinal Chemistry
  • Ron Levy, M.D., Scientific Advisory Board
  • Neal Rosen, M.D., Ph.D., Scientific Advisory Board
  • Charles Sawyers, M.D., Scientific Advisory Board
  • David Schenkein, M.D., Scientific Advisory Board
  • Melika Davis, SVP & Global Head, Clinical Operations
  • Clare Fisher, SVP, Business Development, Licensing, and M&A (ex-China)
  • Tony Guo, Ph.D., SVP, Global Statistics & Data Science
  • Dany Habr, M.D., Head of Medical Affairs, North America & International Markets
  • Graham Hardiman, Global Head of HR
  • Shreya Devendra Jani, SVP, Corporate Affairs
  • Jaspreet Jaggi, M.D., Ph.D., SVP and Head, Clinical Portfolio Strategy
  • Yang Ji, Chief Compliance Officer
  • Mark Lanasa, M.D., Ph.D., SVP, Chief Medical Officer, Solid Tumors
  • Chan Lee, General Counsel
  • Kyu-Sung Lee, Ph.D., SVP, Global Head of Technical Operations and Manufacturing
  • Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer
  • Kyoung Lim, VP of Supply Chain
  • Han Ma, M.D., Ph.D., Chief Safety Officer and SVP, Global Patient Safety
  • Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology
  • Richard O’Keeffe, Head of Global Quality
  • Jurij Petrin, M.D., Head of New Market Development
  • Yan Qi, Ph.D., SVP, Head of Public Affairs
  • Hongyu Qian, SVP, Medical Affairs
  • Jason Radford, SVP, Strategy & Corporate Development
  • Anand Reddi, VP, Global Strategic Initiatives and Corporate Operations, Chief of Staff to the CEO
  • Adam Roach, VP and Head of Asia Pacific
  • Aaron Rosenberg, Chief Financial Officer
  • Michael Schoen, Strategic Advisor and Special Assistant to the CEO
  • Matt Shaulis, General Manager of North America
  • Lai Wang, Ph.D., Global Head of R&D
  • Zhiwei Wang, Ph.D., SVP, Research Head of Chemistry
  • Beth Wensley, SVP, Head of Portfolio and Program Management
  • Kimberly Wolf, SVP, Global Commercial Strategy & Operations
  • Xiaobin Wu, Ph.D., President, Chief Operating Officer
  • Eva Yin, Chief Commercial Officer, Greater China

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. logo
Market Cap: Highest
Employees: High

Vimizim

Bio Marin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Their products cater to conditions like mucopolysaccharidosis, phenylketonuria, Batten disease, and more.

Tags: biotechnology, enzyme replacement therapy, healthcare, pharmaceutical, rare diseases

Symbol: BMRN

Recent Price: $65.45

Industry: Biotechnology

CEO: Mr. Alexander Hardy

Sector: Healthcare

Employees: 3401

Address: 770 Lindaro Street, San Rafael, CA 94901

Phone: 415 506 6700

Leadership

  • Mark Enyedy,
  • Alexander Hardy,
  • Elaine J. Heron,
  • G. Eric Davis, Executive Vice President, Chief Legal Officer
  • Greg Friberg, Executive Vice President, Chief Research & Development Officer
  • C. Greg Guyer, Executive Vice President, Chief Technical Officer
  • Cristin Hubbard, Executive Vice President, Chief Commercial Officer
  • Marni Kottle, Executive Vice President, Chief Corporate Affairs Officer
  • Brian R. Mueller, Executive Vice President, Chief Financial Officer
  • James Sabry, Executive Vice President, Chief Business Officer
  • Amy Wireman, Executive Vice President, Chief People Officer
  • Richard A. Meier,
  • Elizabeth McKee Anderson,
  • Barbara Bodem,
  • Athena Countouriotis,
  • Willard H. Dere,
  • Maykin Ho,
  • Robert J. Hombach,
  • David E.I. Pyott,

Last updated: 2024-12-31

BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

IGALMI

Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.

Tags: agitation treatment, artificial intelligence, biopharmaceutical, clinical trials, immuno-oncology, neuroscience

Symbol: BTAI

Recent Price: $0.37

Industry: Biotechnology

CEO: Dr. Vimal D. Mehta Ph.D.

Sector: Healthcare

Employees: 74

Address: 555 Long Wharf Drive, New Haven, CT 06511

Phone: 475 238 6837

Last updated: 2024-12-31

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Fadraciclib, CYC140, Sapacitabine, Seliciclib

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of medicines for treating cancer and other proliferative diseases. The company's key development programs include fadraciclib, CYC140, Sapacitabine, and seliciclib, targeting various forms of cancer and other conditions.

Tags: CDK inhibitors, biopharmaceutical, cancer treatment, clinical trials, proliferative diseases

Symbol: CYCC

Recent Price: $0.37

Industry: Biotechnology

CEO: Mr. Spiro George Rombotis

Sector: Healthcare

Employees: 12

Address: 200 Connell Drive, Berkeley Heights, NJ 07922

Phone: 908 517 7330

Last updated: 2024-12-31

Incyte Corporation

Incyte Corporation logo
Market Cap: Highest
Employees: High

JAKAFI, PEMAZYRE, ICLUSIG

Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics, with products like JAKAFI, PEMAZYRE, and ICLUSIG for various cancer treatments.

Tags: ICLUSIG, JAKAFI, PEMAZYRE, biopharmaceutical, cancer treatment, clinical trials, oncology, therapeutics

Symbol: INCY

Recent Price: $68.42

Industry: Biotechnology

CEO: Mr. Herve Hoppenot

Sector: Healthcare

Employees: 2524

Address: 1801 Augustine Cut-Off, Wilmington, DE 19803

Phone: 302 498 6700

Leadership

  • HervΓ© Hoppenot, Chairman and Chief Executive Officer
  • Paula J. Swain, Executive Vice President, Human Resources
  • Pablo J. Cagnoni, M.D., President, Head of Research and Development
  • Steven H. Stein, M.D., Executive Vice President and Chief Medical Officer
  • Sheila A. Denton, J.D., Executive Vice President and General Counsel
  • Christiana Stamoulis, MBA, Executive Vice President and Chief Financial Officer
  • Barry P. Flannelly, PharmD, MBA, Executive Vice President and General Manager, North America
  • Denise Brashear, Vice President, Head of Global Communications
  • Vijay Iyengar, M.D., Executive Vice President, Global Medical Affairs, Product, and Partnership Strategy (GMAP2S)
  • Lee Heeson, Executive Vice President, Head of Incyte International
  • Michael Morrissey, Executive Vice President and Head of Global Technical Operations
  • Matteo Trotta, MBA, Executive Vice President, General Manager, U.S. Dermatology
  • Xiaozhao Wang, Ph.D., Associate Vice President, Head of Medicinal Chemistry
  • Julian C. Baker, Managing Partner
  • Jean-Jacques Bienaime, Former Chief Executive Officer
  • Otis Brawley, M.D., Bloomberg Distinguished Professor of Oncology and Epidemiology
  • Paul J. Clancy, Former Executive Vice President and Senior Advisor
  • Jacqualyn A. Fouse, Ph.D., Former Chief Executive Officer
  • Edmund P. Harrigan, M.D., Former Senior Vice President of Worldwide Safety and Regulatory
  • Katherine High, M.D., Former President and Head of Research and Development
  • Susanne Schaffert, Ph.D., Former President

Last updated: 2024-12-31

MediciNova, Inc.

MediciNova, Inc. logo
Market Cap: Low
Employees: Lowest

MN-166 (ibudilast)

Medici Nova, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious diseases with unmet medical needs, including neurologic disorders, fibrotic diseases, and solid tumor cancers.

Tags: United States, biopharmaceutical, fibrotic diseases, neurological disorders, novel therapeutics, solid tumors, unmet medical needs

Symbol: MNOV

Recent Price: $2.11

Industry: Biotechnology

CEO: Dr. Yuichi Iwaki M.D., Ph.D.

Sector: Healthcare

Employees: 13

Address: 4275 Executive Square, La Jolla, CA 92037

Phone: 858 373 1500

Leadership

  • Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, and Founder
  • Kazuko Matsuda, M.D., Ph.D, MPH, Chief Medical Officer
  • David H. Crean, Ph.D., Chief Business Officer
  • Jason J. Kruger, CPA (inactive), Chief Financial Officer
  • Hideki Nagao, Member of the Board of Directors
  • Carolyn Beaver, Member of the Board of Directors
  • Nicole Lemerond, CFA, Member of the Board of Directors

Last updated: 2024-12-31

Vaxcyte, Inc.

Vaxcyte, Inc. logo
Market Cap: Highest
Employees: Low

VAX-24

Vaxcyte, Inc. is a clinical-stage biotechnology company developing novel protein vaccines for preventing or treating bacterial infectious diseases. Key products include the VAX-24 pneumococcal conjugate vaccine and other candidates targeting antibiotic resistance and periodontitis.

Tags: bacterial infectious diseases, biotechnology, clinical-stage, pharmaceuticals, protein vaccines, vaccines

Symbol: PCVX

Recent Price: $81.99

Industry: Biotechnology

CEO: Mr. Grant E. Pickering M.B.A.

Sector: Healthcare

Employees: 254

Address: 825 Industrial Road, San Carlos, CA 94070

Phone: 650 837 0111

Last updated: 2024-12-31

Vincerx Pharma, Inc.

Vincerx Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

VIP152

Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company focused on researching and developing therapies to address unmet medical needs for cancer treatment in the United States. Their lead product candidate, VIP152, is a cyclin-dependent kinase-9 inhibitor for advanced cancer.

Tags: biopharmaceutical, cancer treatment, clinical-stage, oncology, therapy development

Symbol: VINC

Recent Price: $0.33

Industry: Biotechnology

CEO: Dr. Ahmed M. Hamdy M.D.

Sector: Healthcare

Employees: 42

Address: 260 Sheridan Avenue, Palo Alto, CA 94306

Phone: 650 800 6676

Last updated: 2024-12-31

2seventy bio, Inc.

2seventy bio, Inc. logo
Market Cap: Low
Employees: Low

idecabtagene vicleucel

2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.

Tags: biotechnology, cancer treatment, cell therapy, gene therapy, multiple myeloma

Symbol: TSVT

Recent Price: $2.89

Industry: Biotechnology

CEO: Mr. William D. Baird III, M.B.A.

Sector: Healthcare

Employees: 274

Address: 60 Binney Street, Cambridge, MA 02142

Phone: 339 499 9300

Last updated: 2024-12-31

Vericel Corporation

Vericel Corporation logo
Market Cap: High
Employees: Low

MACI, Epicel, NexoBrid

Vericel Corporation is a commercial-stage biopharmaceutical company focusing on the development, manufacture, and distribution of cellular therapies for sports medicine and burn care in the United States. Their products include MACI for cartilage repair and Epicel for burn treatment.

Tags: United States, autologous cell therapy, biopharmaceutical, burn care, cellular therapies, sports medicine

Symbol: VCEL

Recent Price: $55.30

Industry: Biotechnology

CEO: Mr. Dominick C. Colangelo Esq.

Sector: Healthcare

Employees: 314

Address: 64 Sidney Street, Cambridge, MA 02139

Phone: 617 588 5555

Last updated: 2024-12-31

Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

Imm Celz

Creative Medical Technology Holdings, Inc. is a biotechnology company focusing on using adult stem cell treatments for immunology, urology, orthopedics, and neurology, offering solutions like Caver Stem, Fem Celz, Stem Spine, Imm Celz, and Ova Stem.

Tags: biotechnology, immunology, neurology, orthopedics, stem cell treatments, urology

Symbol: CELZ

Recent Price: $2.34

Industry: Biotechnology

CEO: Mr. Timothy Warbington

Sector: Healthcare

Employees: 4

Address: 211 East Osborn Road, Phoenix, AZ 85012

Phone: 480 399 2822

Last updated: 2024-12-31

Exelixis, Inc.

Exelixis, Inc. logo
Market Cap: Highest
Employees: Medium

CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO

Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.

Tags: biotechnology, cancer treatment, oncology, pharmaceuticals

Symbol: EXEL

Recent Price: $33.70

Industry: Biotechnology

CEO: Dr. Michael M. Morrissey Ph.D.

Sector: Healthcare

Employees: 1310

Address: 1851 Harbor Bay Parkway, Alameda, CA 94502

Phone: 650 837 7000

Last updated: 2024-12-31